CANCERVISION
LIVE

Serial Number

97414523

Owner

GENOME INSIGHT, INC.

Attorney

Miriam D. Trudell

First Use Date

Mar 22, 2024

Filing Date

May 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CANCERVISION Trademark

Serial Number: 97414523 • Registration: 8196483

CANCERVISION is a trademark filed by GENOME INSIGHT, INC. on May 17, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENOME INSIGHT, INC. (5 trademarks)

3366 N. Torrey Pines Court, Suite 110
La Jolla, CA 92037

Entity Type: 03

INOCRAS INC.

6330 NANCY RIDGE DRIVE, SUITE 106
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

May 17, 2022

Registration Date

March 31, 2026

First Use Anywhere

March 22, 2024

First Use in Commerce

March 22, 2024

Published for Opposition

March 25, 2025

Goods & Services

Consultancy relating to research in the field of pharmacogenetics; scientific laboratory services namely, solvent testing services; scientific research in the field of genetic engineering; laboratory research in the field of gene expression; scientific research namely, research in the field of gene analysis; genetic testing for scientific research purposes namely, genetic fingerprinting; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetics; scientific research namely, genetic research; genetic testing for scientific research purposes; scientific research; web site design; creating and designing website-based indexes of information for others using information technology; product research namely, research into new products; provision of internet search engines; database development services; development, programming, and implementation of software for others; scientific research namely, research and testing services in the fields of bacteriology and virology; remote monitoring of medical data for medical diagnosis namely, technical and scientific monitoring services relating to medical diagnostic instruments; structural and functional analysis of genomes

Medical and pharmaceutical consultation namely, consultancy and information services relating to biopharmaceutical products; medical services namely, medical and health services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; medical services namely, provision of genetic information for medical treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; psychological consultation; beauty consultation services in the selection and use of cosmetics; consultancy services relating to beauty; providing information about beauty; health spa services namely, cosmetic body care services; pharmaceutical advice; medical services namely, analysis of human biodata for medical purposes; medical services namely, provision of genetic testing for medical treatment purposes; medical services namely, provision of gene therapy for medical treatment purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 9, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 9, 2026 CNPR
EXAMINER'S AMENDMENT ENTERED
Mar 9, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 9, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 9, 2026 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Mar 9, 2026 SNEA
STATEMENT OF USE PROCESSING COMPLETE
Dec 23, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 23, 2025 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 2, 2025 ASGN
USE AMENDMENT FILED
Jun 23, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 23, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 20, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 3, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 3, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 3, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 3, 2025 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 14, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 14, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 14, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 14, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 16, 2024 RCCK
ASSIGNED TO EXAMINER
Feb 15, 2024 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 5, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 11, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 11, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 11, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 13, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2022 NWOS
NEW APPLICATION ENTERED
May 20, 2022 NWAP